Tallinn Medical Research Ethics Committee will end its activities as of August 14, 2019 (TMERC protocol number 238, March 14, 2019).
Proposals can be submitted for evaluation until May 29 (the respective meeting will be held June 13). Until September, TMERC will also evaluate substantial amendments of previously approved studies.
The Tallinn Medical Research Ethics Committee is an independent expert body that operates at the National Institute for Health Development, evaluating the projects of biomedical research involving human subjects.
The aim of the Ethics Committee is to ensure protection of health, dignity, identity, security of person and other fundamental rights and freedoms of all research participants in medical science and health surveys. In order to do so, the committee evaluates the scientific value, feasibility, legality and other ethical aspects of the planned research.
The Tallinn Medical Research Ethics Committee comprises of 11 members. The members of the Ethics Committee are elected according to the representation of medical specialities from institutions in Tallinn, involving also non-medical specialists (a lawyer, psychologist, theologian etc.).
The work format of the Ethics Committee is meetings, which are held once a month, except in July.
NB! Starting from the January 1, 2018, the following fees apply for the evaluation of the clinical trials and their amendments (according to the Medicinal Products Act):
- 383 euros for the initial evaluation of the clinical trial
- 100 euros for the evaluation of a substantial amendment.
Please also see the Communication from the European Commission 2010/C 82/01 for the examples of substantial amendments
|Deadline for the submission of the documents||Date of the meeting|
|January 30, 2019||February 14, 2019|
|February 27, 2019||March 14, 2019|
|April 3, 2019||April 18, 2019|
|May 2, 2019||May 16, 2019|
|May 29, 2019||June 13, 2019|
Tallinn Medical Research Ethics Committee
National Institute for Health Development
Tallinn 11619, Estonia
Tel: +372 659 3924
Fax: +372 659 3901